Intelligence Platform

Patents

Browse 763 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6794505

Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic

Miravant Pharmaceuticals, Inc. · Granted Tue Sep 21 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6787573

Antiviral therapy

Universitair Medisch Centrum Utrecht · Granted Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6756201

Diagnostic methods and gene therapy using reagents derived from the human metastasis suppr

The United States of America as represented by the Department of Health and Services · Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6756408

Methods and materials for protecting against myocardial cell damage related to coronary in

The Board of Regents of the University of Texas System · Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6747013

Therapy for cellular accumulation in chronic inflammatory diseases

The Regents of the University of California · Granted Tue Jun 08 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6709858

Hyperthermic inducible expression vectors for gene therapy and methods of use thereof

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Mar 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6696064

Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-ba

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6683058

Methods for therapy of neurodegenerative disease of the brain

The Regents of the University of California · Granted Tue Jan 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6669935

Delivery of therapeutic agents by gene therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6667041

Use of neurotoxin therapy for treatment of urologic and related disorders

The Regents of the University of Colorado · Granted Tue Dec 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6660750

Flavopiridol methods and compositions for HIV therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6653351

Adjuvant chemotherapy for anaplastic gliomas

The Board of Regents of the University of Texas System · Granted Tue Nov 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6638543

Use of natural EGFR inhibitors to prevent side effects due to retinoid therapy, soaps, and

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6630124

Combination therapy with VIP antagonist

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6627615

Methods and compositions for in vivo gene therapy

The Regents of the University of California · Granted Tue Sep 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6613757

COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT

The Board of Regents of the University of Texas System · Granted Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6579857

Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors

EVANSTON NORTHWESTERN HEALTHCARE RESEARCH INSTITUTE · Granted Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6576463

Hybrid vectors for gene therapy

The Regents of the University of California · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6566342

Gene therapy by secretory gland expression

The Regents of the University of California · Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6565827

Radioimmunotherapy of lymphoma using anti-CD20 antibodies

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6551588

Tumor radiosensitization using gene therapy

The Regents of the University of California · Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6548055

Immunologic enhancement with intermittent interleukin-2 therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6514695

Compositions and methods for intraductal gene therapy

The Regents of the University of California · Granted Tue Feb 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6451306

Methods for therapy of neurodegenerative disease of the brain

The Regents of the University of California · Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired